357 related articles for article (PubMed ID: 1982548)
1. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
2. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
3. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
[TBL] [Abstract][Full Text] [Related]
4. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
Yamaura T; Shibata M; Chida Y; Inaba N; Onodera S; Ohnishi H
Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
[TBL] [Abstract][Full Text] [Related]
5. [Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats].
Yamaura T; Shibata M; Inaba N; Onodera S; Chida Y; Ohnishi H
Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):401-10. PubMed ID: 1356897
[TBL] [Abstract][Full Text] [Related]
6. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
7. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Palacios B; Montero MJ; Sevilla MA; Román LS
Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
10. [Studies on histamine H2-receptor antagonistic property of FRG-8813, a novel anti-ulcer drug].
Inaba N; Shibata M; Onodera S; Tanaka M; Suzuki T; Yamaura T; Ohnishi H
Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):231-41. PubMed ID: 7774860
[TBL] [Abstract][Full Text] [Related]
11. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
[TBL] [Abstract][Full Text] [Related]
12. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats.
Onodera S; Shibata M; Tanaka M; Inaba N; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1995 Jun; 68(2):161-73. PubMed ID: 7563973
[TBL] [Abstract][Full Text] [Related]
13. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
14. Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage.
Ichikawa T; Ishihara K; Komuro Y; Kojima Y; Saigenji K; Hotta K
Life Sci; 1994; 54(10):PL159-64. PubMed ID: 7509019
[TBL] [Abstract][Full Text] [Related]
15. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
[TBL] [Abstract][Full Text] [Related]
16. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
[TBL] [Abstract][Full Text] [Related]
17. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
Scarpignato C; Tramacere R; Zappia L
Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
[TBL] [Abstract][Full Text] [Related]
18. [Effects of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus in rats].
Kagoshima M; Kodaira H; Shimada H
Nihon Yakurigaku Zasshi; 1994 Nov; 104(5):379-89. PubMed ID: 7829023
[TBL] [Abstract][Full Text] [Related]
19. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
Okabe S; Takeuchi K; Urushidani T; Takagi K
Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
[TBL] [Abstract][Full Text] [Related]
20. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]